Catalog |
name |
Description |
price |
R-XASYS-00597 |
3-Hydroxyacetaminophen,cas:37519-14-5 |
3-Hydroxyacetaminophen (3-HAP)(C8H9NO3,167.16) is an active metabolite of acetaminophen, which is widely used as an analgesic and antipyretic drug. It is produced in the body by the oxidation of acetaminophen by cytochrome P450 enzymes. 3-HAP is a key intermediate in the metabolism of acetaminophen and is thought to be responsible for some of the toxic effects of acetaminophen. |
price> |
R-XASYS-00598 |
Acetylazide,cas:3590-05-4 |
Acetylazide(C13H14N4O4S,322.34) is a synthetic broad-spectrum bacteriostatic antibiotic. |
price> |
R-XASYS-00599 |
Acid Ceramidase-IN-1,cas:2415225-30-6 |
Acid Ceramidase-IN-1(C18H25N3O3,331.41) is a potent and oral bioavailable acid ceramidase (AC,ASAH-1) inhibitor (hAC IC50=0.166μM). Acid Ceramidase-IN-1 has excellent brain penetration in mice |
price> |
R-XASYS-00600 |
Aclacinomycin A,cas:57576-44-0 |
Aclarubicin(C42H53NO15,811.9) is an anthracycline antibiotic derived from Streptomyces galbus, a soil-borne actinomycete. It is a type of chemotherapy drug used in the treatment of various types of cancer. |
price> |
R-XASYS-00601 |
Aclacinomycin A hydrochloride,cas:75443-99-1 |
Aclarubicin hydrochloride (ACL)(C42H54ClNO15,848.3) is an anthracycline antibiotic developed by the Japanese pharmaceutical company, Daiichi Sankyo. It is derived from the bacterium Streptomyces peucetius and is structurally related to doxorubicin. |
price> |
R-XASYS-00602 |
Acoziborole,cas:1266084-51-8 |
Acoziborole(C17H14BF4NO3,367.10), also known as SCYX-7158 is an orally-active compound with potent antitrypanosoma activity for the potent treatment of stage 2 human African trypanosomiasis. |
price> |
R-XASYS-00603 |
ACP-105,cas:899821-23-9 |
ACP-105(C16H19ClN2O,290.79) is an orally available, selective amd potent androgen receptor modulator (SARM), with pEC50s of 9.0 and 9.3 for AR wild type and T877A mutant, respectively. |
price> |
R-XASYS-00604 |
Acrizanib,cas:1229453-99-9 |
Acrizanib(C20H18F3N7O2,445.41),also known as LHA510, is a potent and selective angiogenesis inhibitor and VEGFR-2 Inhibitor Specifically Designed for Topical Ocular Delivery, as a Therapy for Neovascular Age-Related Macular Degeneration. |
price> |
R-XASYS-00605 |
Palosuran,cas:540769-28-6 |
Palosuran (ACT-058362)(C25H30N4O2,418.5) is a potent, selective, and orally active antagonist of urotensin II receptor, with an IC50 of 3.6 nM for CHO cell membranes expressing human recombinant receptors. Palosuran can improves pancreatic and renal function in diabetic rats. |
price> |
R-XASYS-00606 |
ACT-709478,cas:1838651-58-3 |
ACT-709478(C22H18F3N5O,425.4) is a potent, selective, orally active, and brain penetrating T-type calcium channel blocker. ACT-709478 is used in the research of generalized epilepsies. |
price> |